Gujarat Alkalies and Chemicals Limited Fair Value

GUJALKALI · Chemicals · Current price ₹587.95

Full stock page
DocStoX fair value
₹465
low confidence · 40/100
Current price
₹705
Upside to fair value
-34.0%
Estimate range
₹419 – ₹512
Quality score
3.1 / 10
Model it yourself — Margin of Safety Calculator
Opens pre-filled with Gujarat Alkalies and Chemicals Limited's latest numbers.

Is Gujarat Alkalies and Chemicals Limited undervalued?

We estimate the fair value of Gujarat Alkalies and Chemicals Limited at ₹465 per share, against a market price of ₹705. That puts the share price about -34.0% above our estimate, at low confidence. This is our view of what the business is worth, not a target price or a forecast of where the share price will go.

How this fair value is calculated

This estimate comes from 1 method: Normalized earnings (mid-cycle EV/EBITDA) (₹465). Each is weighted by how well its inputs held up for this company. The full working, including the assumptions and what data was missing, is set out below.

The range around this estimate

Our estimate for Gujarat Alkalies and Chemicals Limited spans ₹419 to ₹512. That range is wide, which is the honest signal here: read the range rather than the single number. A margin of safety means buying meaningfully below the estimate: the wider the range, the more room the assumptions leave for error.

How we got this fair value

Every number below is part of the same estimate for Gujarat Alkalies and Chemicals Limited. Nothing here is a target price or a forecast of where the share price will go.

Low confidence40/100

The inputs are thin or the models disagree sharply. This is our least reliable kind of estimate, so read the range rather than the single number.

Estimate range ₹419 – ₹512

Why this method for this business

As a cyclical commodity chemical company, we value off mid-cycle earnings and a through-cycle EV/EBITDA. Normalized earnings and EV/EBITDA are the most defensible methods for this sector.

The models behind the number

Each method is weighted by how well its inputs held up for this company.

Normalized earnings (mid-cycle EV/EBITDA)
₹46580% weight

Cyclical valued off mid-cycle earnings and a through-cycle EV/EBITDA (§6.6)

EV / EBITDA(not enough data)

required inputs missing

  • Relative P/E is rejected due to data errors and the cyclical nature of the business
  • DCF is not used due to lack of forward estimates and the volatile earnings profile

What was missing

  • Forward estimates are not available
  • No recent news impacting the valuation

What drives it

7 inputs, grouped by how strong each claim is
ReportedRead from filings or market data. Verifiable, not our opinion.
Revenue (TTM)
4,358 ₹ cr

computed

Net debt
417.8 ₹ cr

computed

Shares outstanding
7,39,43,662

computed

AssumptionA forward input the model chose. Reasonable people can disagree here.
EBITDA margin (cycle median)
9%

computed (≤5y median)

Through-cycle EV/EBITDA
9.83×

own-history (median of 4y)

DerivedFalls out of the inputs above: a model output, not an independent input.
Mid-cycle EBITDA
392.2 ₹ cr

computed

Enterprise value
3,856.8 ₹ cr

computed

Who computed this

A language model (qwen3:8b) selects the valuation method and the judgement inputs for Gujarat Alkalies and Chemicals Limited: which models suit the business, the moat, the growth and margin assumptions. It does not produce the number. The fair value itself is computed in Python by a deterministic engine (version 2026.08.1) from those inputs, so the same inputs always give the same result and every figure above can be traced to a source.

Estimated 14 Sept 2026. Re-run as new financials and news arrive.

How we value stocks

We estimate what a business is worth from its own economics: cash flows, returns on capital, and a multiple justified by its quality, rather than from where the share price has been. A fair value estimate is a view, not a verdict, and it is only as good as the inputs listed above.

Read the full fair-value methodology

More on Gujarat Alkalies and Chemicals Limited

DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.